文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

腹部动脉粥样硬化并非危重症患者非闭塞性肠系膜缺血的危险因素:一项倾向性匹配研究

Abdominal atherosclerosis is not a risk factor of nonocclusive mesenteric ischemia among critically ill patients: a propensity matching study.
PubMed 文献 · Ann Intensive Care · 2022-12-24
一句话结论在因疑似非闭塞性肠系膜缺血(NOMI)行增强CT的危重症患者中,腹部动脉钙化评分与NOMI无显著关联,提示动脉粥样硬化可能不是NOMI的危险因素。

本研究纳入2018年1月至2021年12月连续入住ICU、因疑似NOMI行增强CT的165例危重症患者,其中59例(36%)发生NOMI。回顾性提取CT时临床与生物学数据,由单一放射科医师用平扫CT按Agatston法计算腹主动脉、腹腔干、肠系膜上动脉(SMA)及髂总动脉钙化评分,并按1:1倾向性评分匹配。匹配前SMA钙化评分52.00(IQR 0,473)vs 137.00(IQR 0,259),P=0.857;总腹部Agatston评分7253(IQR 1220,21738)vs 5802(IQR 2075,15084),P=0.723。匹配38对后结果相似:SMA 153(IQR 0,665)vs 85(IQR 0,240),P=0.312;总腹部7915(IQR 1812,21561)vs 4139(IQR 1440,9858),P=0.170。作者认为动脉粥样硬化不是危重症患者NOMI的危险因素。

要点

  • 在165例因疑似NOMI行增强CT的危重症患者中,59例(36%)发生NOMI。
  • 匹配前,无NOMI组与NOMI组的SMA钙化评分分别为52.00(IQR 0,473)和137.00(IQR 0,259),P=0.857。
  • 匹配前,无NOMI组与NOMI组的总腹部Agatston钙化评分分别为7253(IQR 1220,21738)和5802(IQR 2075,15084),P=0.723。
  • 倾向性匹配38对后,SMA钙化评分分别为153(IQR 0,665)和85(IQR 0,240),P=0.312。
  • 倾向性匹配后,总腹部Agatston钙化评分分别为7915(IQR 1812,21561)和4139(IQR 1440,9858),P=0.170。

适用人群与场景

  • 2018年1月至2021年12月连续入住ICU、因疑似NOMI行增强CT的危重症患者。

研究设计与关键结果

  • 研究类型:倾向性匹配研究;样本量165例,其中NOMI 59例(36%)。
  • 干预与对照:比较无NOMI与有NOMI患者的腹部钙化评分,并按1:1倾向性评分匹配基于临床、生物学数据及腹部CT特征。
  • 主要终点:匹配前SMA钙化评分无NOMI组52.00(IQR 0,473)vs NOMI组137.00(IQR 0,259),P=0.857;总腹部Agatston评分无NOMI组7253(IQR 1220,21738)vs NOMI组5802(IQR 2075,15084),P=0.723。
  • 匹配后:38例NOMI与38例无NOMI,SMA钙化评分153(IQR 0,665)vs 85(IQR 0,240),P=0.312;总腹部Agatston评分7915(IQR 1812,21561)vs 4139(IQR 1440,9858),P=0.170。

证据类型、等级与局限

  • 证据类型:倾向性匹配研究(回顾性提取数据),单一放射科医师审阅。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,动脉粥样硬化不是危重症患者NOMI的危险因素,提示对疑似NOMI的危重症患者,腹部动脉钙化评分可能不改变临床对NOMI风险的评估。
  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Although risk factors of occlusive acute mesenteric ischemia are well known, triggering factors of nonocclusive mesenteric ischemia (NOMI) remain unclear. Alongside to the known risk factors for NOMI, the role of atherosclerosis is not fully elucidated. The purpose of our study was to evaluate whether abdominal atherosclerosis is a risk factor for NOMI.

METHODS: From January 2018 to December 2021, all consecutive patients admitted to the intensive care unit who underwent contrast-enhanced CT for suspicion of NOMI were evaluated for inclusion. Clinical and biological data at the time of the CT scan were retrospectively extracted from medical charts and reviewed by a single radiologist. The cohorts were matched by a 1:1 propensity score based on the patient clinical, biological data, and abdominal CT features associated with NOMI. Noncontrast CT acquisitions were used to calculate calcium scores of the abdominal aorta, celiac trunk, superior mesenteric artery (SMA), and common iliac artery according to the Agatston method. Analyses were performed before and after propensity score matching.

RESULTS: Among the 165 critically ill patients included, 59 (36%) had NOMI. Before matching analysis, the SMA and total abdominal Agatston calcium scores were not different between patients without and with NOMI (52.00 [IQR = 0, 473] vs. 137.00 [IQR = 0, 259], P = 0.857, respectively, and 7253 [IQR = 1220, 21738] versus 5802 [IQR = 2075, 15,084]; P = 0.723). The results were similar after matching 38 patients with NOMI and 38 without: 153 [IQR = 0, 665] versus 85 [IQR = 0, 240] (P = 0.312) for the SMA calcium score, and 7915 [IQR = 1812, 21561] versus 4139 [IQR = 1440, 9858] (P = 0.170) for the total abdominal Agatston calcium score.

CONCLUSION: Our results suggest that atherosclerosis is not a risk factor for NOMI in critically ill patients.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Konan A, Piton G, Ronot M, et al. Abdominal atherosclerosis is not a risk factor of nonocclusive mesenteric ischemia among critically ill patients: a propensity matching study. Ann Intensive Care. 2022. PMID: 36565393. doi:10.1186/s13613-022-01096-4

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。